FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreps, D. M.
Right arrow Articles by Toews, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreps, D. M.
Right arrow Articles by Toews, M. L.

The FASEB Journal, Vol 7, 1376-1380, Copyright © 1993 by The Federation of American Societies for Experimental Biology


RESEARCH COMMUNICATIONS

Lysophosphatidic acid mimics serum-induced sensitization of cyclic AMP accumulation

DM Kreps, SM Whittle, JM Hoffman and ML Toews
Department of Pharmacology, University of Nebraska Medical Center, Omaha 68198-6260.

Pretreatment of 1321N1 human astrocytoma cells with serum induces a pronounced increase in subsequent stimulation by forskolin and other agents of intracellular cyclic AMP accumulation, a phenomenon referred to as sensitization (Mol. Pharmacol. 39, 399-406, 1991). Pretreatment of these cells with lysophosphatidic acid induced sensitization to a similar extent as that with serum (approximately fivefold for forskolin stimulation and twofold for isoproterenol and prostaglandin E1 stimulation), with half-maximal effects at approximately 30 nM lysophosphatidic acid. Phosphatidic acid was effective but less potent whereas other lipids were ineffective. Sensitization by serum and by lysophosphatidic acid were almost completely inhibited by pertussis toxin pretreatment and partially inhibited by prolonged phorbol ester exposure to induce protein kinase C down-regulation. Among nine cell lines tested, those that exhibited sensitization with serum showed comparable sensitization with lysophosphatidic acid. The effects of both lysophosphatidic acid and serum were markedly inhibited by treatment with phospholipase B but only minimally altered with phospholipases A2, D, and C. Exposure of cells to phospholipase C alone induced approximately threefold sensitization, but both serum and lysophosphatidic acid were able to induce further three- to fourfold sensitization above that induced by phospholipase C alone. In contrast, the effects of serum and lysophosphatidic acid were not additive with each other. Together these results suggest that lysophosphatidic acid or a closely related compound present in serum is the factor responsible for sensitization of the cyclic AMP pathway.


This article has been cited by other articles:


Home page
IOVSHome page
W. B. Thoreson, J. S. Ryan, C. Shi, M. E. Kelly, E. J. Bryson, M. L. Toews, T. L. Ediger, and D. M. Chacko
Lysophosphatidic Acid Receptor Signaling in Mammalian Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2450 - 2461.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. L. Ediger and M. L. Toews
Synergistic Stimulation of Airway Smooth Muscle Cell Mitogenesis
J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1076 - 1082.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
M. L. Toews, E. E. Ustinova, and H. D. Schultz
Lysophosphatidic acid enhances contractility of isolated airway smooth muscle
J Appl Physiol, October 1, 1997; 83(4): 1216 - 1222.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by The Federation of American Societies for Experimental Biology.